Choo, Richard <br/><br/>
Prospective study evaluating postoperative radiotherapy plus 2-year androgen suppression for post-radical prostatectomy patients with pathologic T3 disease and/or positive surgical margins.  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  Oct 2009 
 - 407-12 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-355X 
<br/><br/><label>Standard No.: </label>10.1016/j.ijrobp.2008.11.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Androgen Antagonists--therapeutic use<br/>Buserelin--therapeutic use<br/>Combined Modality Therapy--methods<br/>Humans<br/>Imidazolidines--therapeutic use<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--blood<br/>Neoplasm Staging<br/>Neoplasm, Residual<br/>Pilot Projects<br/>Prospective Studies<br/>Prostate-Specific Antigen--blood<br/>Prostatectomy<br/>Prostatic Neoplasms--drug therapy<br/>Regression Analysis<br/>Survival Rate